Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015

• Egile Nagusiak: F. Torres-Bondia (Egilea), J. de Batlle (Egilea), L. Galván (Egilea), M. Buti (Egilea), F. Barbé (Egilea), G. Piñol-Ripoll (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2022-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Proton pump inhibitors (PPIs) are one of the most commonly prescribed pharmacological groups. Their high prevalence and duration of use are of important health concern due to the risk they can cause to patients. Despite these risks, their use remains particularly high, especially...